Impaired cardiac autonomic control relates to disease severity in pulmonary hypertension

Wensel R., Jilek C., Dorr M., Francis D. P., Stadler H., Lange T., Blumberg F., Opitz C., Pfeifer M., Ewert R.

Source: Eur Respir J 2009; 34: 895-901
Journal Issue: October
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Wensel R., Jilek C., Dorr M., Francis D. P., Stadler H., Lange T., Blumberg F., Opitz C., Pfeifer M., Ewert R.. Impaired cardiac autonomic control relates to disease severity in pulmonary hypertension. Eur Respir J 2009; 34: 895-901

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Altered control of cerebral circulation in chronic obstructive pulmonary disease: an early sign of cardiovascular autonomic dysfunction
Source: Annual Congress 2008 - COPD
Year: 2008

Impairment of respiratory muscle function in pulmonary hypertension
Source: Annual Congress 2007 - Clinical aspects of pulmonary arterial hypertension
Year: 2007




The link  between dynamic hyperinflation, autonomic dysfunction and exercise testing parameters with masked heart failure  in patients with non-severe obstructive pulmonary disease
Source: Virtual Congress 2020 – Exploring exercise responses in respiratory diseases
Year: 2020


The association between resting and mild-to-moderate exercise pulmonary artery pressure
Source: Eur Respir J 2012; 39: 313-318
Year: 2012



Acute effects of different levels of continuous positive airway pressure on cardiac autonomic modulation in chronic heart failure and chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Physiotherapeutic evaluation and treatment in the acute setting
Year: 2010


Stroke volume and heart rate response to exercise differ in pulmonary arterial hypertension and left heart failure
Source: Annual Congress 2009 - Pulmonary arterial hypertension
Year: 2009


Ivabradine prevents salbutamol-induced disturbance of cardiac autonomic regulation in patients with chronic obstructive pulmonary disease and coronary heart disease
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012

Respiratory muscle dysfunction in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2005; 25: 125-130
Year: 2005



Systemic hypoxia contributes to pulmonary hypertension in heart failure
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011

The importance of cardiac function in pulmonary hypertension
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020

Autonomic dysfunction, cardio-pulmonary parameters and masked heart failure in non-severe chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Respiratory diseases, hypoxia and cardiovascular function
Year: 2020




Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease
Source: Eur Respir Rev 2011; 20: 236-242
Year: 2011



The relationship between autonomic modulation of heart rate variability and sleep breathing disorders in patient with chronic heart failure
Source: Eur Respir J 2006; 28: Suppl. 50, 815s
Year: 2006

Comparison of exercise capacity and exercise haemodynamic relationships between severe group 3 pulmonary hypertension and pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016

Pulmonary hypertension associated with left heart disease
Source: Eur Respir Mon 2012; 57: 119-137
Year: 2012


Effects of a physical training protocol on heart rate kinetics and heart rate variability indexes in patients with pulmonary arterial hypertension.
Source: International Congress 2019 – Exercise and rehabilitation in patients with acute and chronic respiratory diseases
Year: 2019

The effect of long-term specific therapy on clinical outcome, echocardiographic and sympatho-vagal balance as assessed by heart rate variability in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009


Influence of exercise training on cardiac baroreflex sensitivity in patients with COPD
Source: Eur Respir J 2004; 23: 396-401
Year: 2004



Hyperventilation, reduced muscle strength and pulmonary hypertension are the main determinants of chronic dyspnea in chronic heart failure patients
Source: Annual Congress 2008 - Respiratory muscles in disease
Year: 2008